Viveve Medical, Inc. announced that Steve Basta and Karen Zaderej have joined the Viveve board of directors, effective September 13, 2018. Mr. Basta currently serves as chief executive officer of Menlo Therapeutics, Inc. Ms. Zaderej currently serves as chairman, chief executive officer and president of AxoGen, Inc. Mr. Basta currently serves as chief executive officer of Menlo Therapeutics, Inc. Mr. Basta’s previous executive roles include CEO of BioForm Medical, Inc. and its successor, Merz Aesthetics, Inc. where he led BioForm’s growth from product launch to $80.0 million in annual revenues at the time of its acquisition by Merz. He subsequently directed Merz Aesthetics through multiple product launches to reach its position as a worldwide leader in the injectable aesthetics industry. Ms. Zaderej currently serves as chairman, chief executive officer and president of AxoGen, Inc. Her tenure at AxoGen includes roles as the company’s chief operating officer and vice president of marketing and sales. Ms. Zaderej’s professional background also includes building and executing commercialization plans, creating comprehensive market development programs, research and development, and manufacturing while at ETHICON, Inc.